تحميل...
The presence of primary circulating prostate cells is associated with upgrading and upstaging in patients eligible for active surveillance
Active surveillance (AS) is a considered treatment option for men with low or very low-risk prostate cancer. However, on repeat biopsy some 25% were upgraded and recommended for active treatment. We compare the presence or absence of primary circulating prostate cells (CPCs) with the clinical pathol...
محفوظ في:
| الحاوية / القاعدة: | Ecancermedicalscience |
|---|---|
| المؤلفون الرئيسيون: | , , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Cancer Intelligence
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5243134/ https://ncbi.nlm.nih.gov/pubmed/28144285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2017.711 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|